Dexloxiglumide - Moligand™, ≥97% , Cholecystokinin A receptor antagonist, CAS No.119817-90-2, Cholecystokinin A receptor antagonist
In stock
SKU
D172491
Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist . Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8).
More Information
| CAS | 119817-90-2 |
|---|---|
| Synonyms | (R)-4-(3,4-Dichlorobenzamido)-N-(3-methoxypropyl)-N-pentylglutaramic acid | DTXSID50152604 | (R)-4-(3,4-Dichlorobenzamido)-5-((3-methoxypropyl)(pentyl)amino)-5-oxopentanoic acid | Q5268340 | (+)-LOXIGLUMIDE | (4R)-4-[(3,4-dichlorobenzoyl)amino]-5-(3-metho |
| Specifications & Purity | Moligand™, ≥97% |
| Storage | Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| Product Description |
Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist . Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8).
|
| Pubchem Sid | 528770689 |
| Target | CCKAR |
| PubChem CID | 65937 |
| Molecular Formula | C21H30Cl2N2O5 |
Reviews
Customer Reviews
Remind me later